SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551163-13-000189
Filing Date
2013-11-19
Accepted
2013-11-19 15:16:40
Documents
11
Period of Report
2013-11-19

Document Format Files

Seq Description Document Type Size
1 f10q93013vedgar1.htm 10-Q 252314
3 exhibit311.htm EX-31 8632
4 exhibit312.htm EX-31 9239
5 exhibit321.htm EX-32 4220
6 exhibit322.htm EX-32 4329
  Complete submission text file 0001551163-13-000189.txt   868513

Data Files

Seq Description Document Type Size
7 prtt-20130930.xml EX-101.INS 37840
8 prtt-20130930.xsd EX-101.SCH 8596
9 prtt-20130930_cal.xml EX-101.CAL 14212
10 prtt-20130930_def.xml EX-101.DEF 6118
11 prtt-20130930_lab.xml EX-101.LAB 59831
12 prtt-20130930_pre.xml EX-101.PRE 46856
Mailing Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109
Business Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109 8013223401
PROTECT PHARMACEUTICAL Corp (Filer) CIK: 0001493526 (see all company filings)

IRS No.: 271877179 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54001 | Film No.: 131229810
SIC: 2834 Pharmaceutical Preparations